EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 98 filers reported holding EPIZYME INC in Q3 2016. The put-call ratio across all filers is 7.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $98,000 | +4800.0% | 66,512 | +4334.1% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -98.1% | 1,500 | -96.3% | 0.00% | – |
| Q3 2021 | $207,000 | +1625.0% | 40,402 | +2593.5% | 0.00% | – |
| Q2 2021 | $12,000 | -98.8% | 1,500 | -98.7% | 0.00% | – |
| Q1 2021 | $1,042,000 | +4861.9% | 119,599 | +6002.0% | 0.00% | – |
| Q4 2020 | $21,000 | -27.6% | 1,960 | -20.3% | 0.00% | – |
| Q3 2020 | $29,000 | +20.8% | 2,460 | +64.0% | 0.00% | – |
| Q2 2020 | $24,000 | -89.2% | 1,500 | -89.6% | 0.00% | – |
| Q1 2020 | $223,000 | -65.2% | 14,398 | -44.7% | 0.00% | – |
| Q4 2019 | $640,000 | -64.1% | 26,028 | -84.9% | 0.00% | -100.0% |
| Q3 2019 | $1,781,000 | +53.1% | 172,704 | +86.2% | 0.00% | – |
| Q2 2019 | $1,163,000 | +77.8% | 92,727 | +75.8% | 0.00% | – |
| Q1 2019 | $654,000 | -60.8% | 52,749 | -80.5% | 0.00% | -100.0% |
| Q4 2018 | $1,669,000 | +67.4% | 270,840 | +188.2% | 0.00% | – |
| Q3 2018 | $997,000 | -12.9% | 93,987 | +11.2% | 0.00% | – |
| Q2 2018 | $1,145,000 | -43.8% | 84,503 | -26.4% | 0.00% | -100.0% |
| Q1 2018 | $2,037,000 | +1240.1% | 114,740 | +846.7% | 0.00% | – |
| Q4 2017 | $152,000 | -77.8% | 12,120 | -66.2% | 0.00% | – |
| Q3 2017 | $684,000 | +247.2% | 35,910 | +174.6% | 0.00% | – |
| Q2 2017 | $197,000 | +347.7% | 13,077 | +412.4% | 0.00% | – |
| Q1 2017 | $44,000 | -65.9% | 2,552 | -76.1% | 0.00% | – |
| Q4 2016 | $129,000 | +248.6% | 10,677 | +183.6% | 0.00% | – |
| Q3 2016 | $37,000 | +15.6% | 3,765 | +20.3% | 0.00% | – |
| Q2 2016 | $32,000 | -11.1% | 3,129 | +6.1% | 0.00% | – |
| Q1 2016 | $36,000 | -94.4% | 2,950 | -92.7% | 0.00% | – |
| Q4 2015 | $647,000 | +1602.6% | 40,391 | +1269.2% | 0.00% | – |
| Q3 2015 | $38,000 | -57.3% | 2,950 | -20.9% | 0.00% | – |
| Q2 2015 | $89,000 | +45.9% | 3,729 | +14.7% | 0.00% | – |
| Q1 2015 | $61,000 | +5.2% | 3,250 | +6.1% | 0.00% | – |
| Q4 2014 | $58,000 | – | 3,062 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |